HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Hyeh Ko Selected Research

Extranodal NK-T-Cell Lymphoma

1/2021Metabolic activity of extranodal NK/T cell lymphoma on 18F-FDG PET/CT according to immune subtyping.
12/2020Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
11/2020Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.
1/2020Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.
1/2018Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
1/2018Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay.
9/2017Macrophage inflammatory protein 1 alpha (MIP-1α) may be associated with poor outcome in patients with extranodal NK/T-cell lymphoma.
7/2015Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
3/2015Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator.
12/2009Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Hyeh Ko Research Topics

Disease

36Neoplasms (Cancer)
04/2022 - 12/2002
31Lymphoma (Lymphomas)
04/2022 - 04/2004
18Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2022 - 06/2008
13T-Cell Lymphoma (Lymphoma, T Cell)
07/2022 - 12/2008
10Extranodal NK-T-Cell Lymphoma
01/2021 - 12/2009
8B-Cell Lymphoma (Lymphoma, B Cell)
11/2019 - 04/2010
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2022 - 11/2012
6Disease Progression
01/2022 - 12/2011
5Leukemia
01/2018 - 07/2009
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021 - 10/2004
4Carcinoma (Carcinomatosis)
01/2020 - 06/2006
4Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2019 - 01/2017
4Burkitt Lymphoma (Burkitt's Lymphoma)
06/2013 - 07/2009
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 05/2016
3Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2014
3Fever (Fevers)
09/2020 - 12/2013
3Neutropenia
06/2020 - 12/2013
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2018 - 04/2004
3Large Granular Lymphocytic Leukemia
04/2016 - 01/2008
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2014 - 01/2010
2Epstein-Barr Virus Infections
04/2019 - 02/2016
2Carcinogenesis
03/2017 - 02/2016
2Neoplasm Metastasis (Metastasis)
10/2014 - 03/2011
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2011 - 12/2004
1Subcutaneous panniculitis-like T-cell lymphoma
10/2021
1Stomatitis
06/2020
1Infections
06/2020
1Hyperplasia
06/2020
1Agammaglobulinemia (Hypogammaglobulinemia)
06/2020

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2021 - 04/2010
6Asparaginase (Elspar)FDA Link
11/2020 - 07/2009
6Methotrexate (Mexate)FDA LinkGeneric
02/2020 - 07/2009
6ParaffinIBA
04/2016 - 01/2010
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2020 - 04/2010
5Vincristine (Oncovin)FDA LinkGeneric
06/2020 - 07/2009
5Rituximab (Mabthera)FDA Link
06/2020 - 04/2010
5RNA (Ribonucleic Acid)IBA
01/2018 - 07/2015
5Formaldehyde (Formol)FDA Link
04/2016 - 10/2011
4AnthracyclinesIBA
03/2022 - 05/2015
4Biomarkers (Surrogate Marker)IBA
08/2021 - 12/2017
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 08/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2020 - 04/2010
4LigandsIBA
02/2020 - 05/2015
4Interleukin-10 (Interleukin 10)IBA
01/2020 - 01/2016
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2015 - 12/2009
3Circulating Tumor DNAIBA
04/2022 - 01/2019
3Cell-Free Nucleic AcidsIBA
04/2022 - 01/2019
3CytokinesIBA
12/2020 - 01/2016
3Prednisone (Sone)FDA LinkGeneric
06/2020 - 04/2010
3Monoclonal AntibodiesIBA
01/2020 - 10/2011
3DNA (Deoxyribonucleic Acid)IBA
05/2015 - 10/2014
3Etoposide (VP 16)FDA LinkGeneric
01/2015 - 12/2009
3IfosfamideFDA LinkGeneric
01/2015 - 12/2009
2Anaplastic Lymphoma KinaseIBA
01/2021 - 06/2008
2Programmed Cell Death 1 ReceptorIBA
12/2020 - 04/2019
2B7-H1 AntigenIBA
12/2020 - 02/2020
2carboxyl radical (COO-)IBA
11/2020 - 12/2018
2Ferritins (Ferritin)IBA
09/2020 - 01/2016
2Brentuximab VedotinIBA
04/2020 - 01/2014
2InterleukinsIBA
01/2019 - 01/2016
2Pharmaceutical PreparationsIBA
01/2018 - 01/2017
2ChemokinesIBA
12/2017 - 05/2015
2SurvivinIBA
02/2017 - 03/2015
2Biological ProductsIBA
02/2016 - 06/2015
2Histones (Histone)IBA
02/2016 - 07/2015
2Complementary DNA (cDNA)IBA
06/2015 - 03/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2015 - 02/2011
2Indicators and Reagents (Reagents)IBA
03/2015 - 01/2008
1Phosphotransferases (Kinase)IBA
01/2022
11-(trimethylsilyl)-1H-imidazole (TSIM)IBA
01/2022
1Natural Killer Cell ReceptorsIBA
01/2022
1Fas Ligand Protein (Fas Ligand)IBA
01/2022
1RNA Helicases (RNA Helicase)IBA
01/2022
1Mucin-3IBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
10/2021
1Co-Repressor ProteinsIBA
01/2021
1Genetic Markers (Genetic Marker)IBA
01/2021
1avelumabIBA
12/2020
1MicroRNAs (MicroRNA)IBA
11/2020
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
10/2020
1Transcription Factors (Transcription Factor)IBA
10/2020
1ibrutinibIBA
06/2020
1Sirolimus (Rapamycin)FDA Link
06/2020
1CreatinineIBA
06/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Nuclear Proteins (Protein, Nuclear)IBA
01/2020
1ruxolitinibIBA
11/2019
1pembrolizumabIBA
04/2019

Therapy/Procedure

19Drug Therapy (Chemotherapy)
07/2022 - 07/2005
10Therapeutics
03/2022 - 12/2011
4Radiotherapy
04/2019 - 04/2004
3Immunotherapy
08/2021 - 01/2016
3Aftercare (After-Treatment)
12/2020 - 02/2015
3Chemoradiotherapy
06/2018 - 12/2009
3Stem Cell Transplantation
01/2017 - 01/2015
3Hematopoietic Stem Cell Transplantation
04/2016 - 12/2008
2Ligation
06/2015 - 03/2014
2Combination Drug Therapy (Combination Chemotherapy)
12/2013 - 09/2004
1Precision Medicine
11/2020
1Salvage Therapy
04/2019